Haier Biomedical Publishes 2025 Sustainability Report: Committed to Building a Platform for Technology, Industry and Social Responsibility | Corporate

QINGDAO, China, May 20, 2026 /PRNewswire/ — Haier Biomedical (688139.SH), a world chief in life sciences and medical options, has launched its 2025 Sustainability Report, offering a complete overview of the corporate’s measurable progress achieved in environmental, social, and governance with dedication to safer, greener, and extra inclusive, accessible healthcare and life sciences worldwide.

Within its LIFE sustainability framework of Leadership, Integrity, Future, and Ecosystem, Haier Biomedical actively helps and implements all 17 United Nations Sustainable Development Goals (SDGs). Through steady technological innovation and domestically built-in methods in world markets, the corporate empowers public well being initiatives worldwide with key focuses of strengthening localized service networks, advancing cutting-edge scientific analysis, and driving sustainable improvement throughout industrial chains with modern low-carbon options.

“In 2025, we achieved three strategic leaps: from products to scenarios, from China to the world, and from a single industry to a platform ecosystem. Guided by our philosophy of ‘Intelligent of Life Science,’ Haier Biomedical continues to deepen green, low‑carbon innovation and global health accessibility under our core ‘LIFE’ framework,” stated Tan Lixia, Chairwoman of Haier Biomedical.

Haier Biomedical stays dedicated to making R&D and innovation a strategic precedence. It has established a clear three-tier R&D administration construction that balances useful resource allocation, drives technological breakthroughs, and accelerates new product improvement. Guided by the twin engines of core know-how development and deep consumer perception, the corporate ensures strategic alignment by mechanisms reminiscent of milestone evaluations by the administration committee, month-to-month progress reviews, and weekly operational conferences. This strategy has yielded sturdy outcomes:

• R&D personnel account for 28.56% of the workforce, with whole R&D funding reaching 323 million yuan (USD 47.25 million);
• New invention patents grew 50% year-on-year, and non-storage patents now signify 73% of the portfolio;
• It holds 428 software program copyrights and has accrued 51 provincial or higher-level science and know-how awards, in addition to involvement in setting 75 nationwide, trade, group, and technical requirements;
• Owns 34 applied sciences acknowledged as internationally main and a monitor document of 0.70 patents and 0.18 software program copyrights per million yuan in income.

Haier Biomedical is integrating AI into product R&D, launching “AI+” options that tackle key security and environment friendly ache factors in healthcare:

• The “AI+” Safety Cabinet, skilled on over 7,000 annotated medication vial pictures, achieves 99% recognition accuracy, masking 101 widespread vial varieties and considerably decreasing medicine errors.
• The Cytotoxic Drug Dispensing Robot with 3D-AI imaginative and prescient is developed for absolutely automated chemotherapy preparation, defending healthcare employees from hazardous publicity.
• Its Fully Automated Cell Culture Workstation allows closed-loop cell processing from thawing to harvesting, bettering standardization and traceability whereas decreasing labor prices.

These improvements earned Haier Biomedical a second prize on the 2025 Qingdao Science and Technology Progress Award and first prize on the Shandong Provincial Science and Technology Progress Award.

In addition, Haier Biomedical has established a digitalized high quality administration course of masking all the journey from uncooked materials consumption to product dispatch, integrating digital capabilities into each side of manufacturing and high quality management to drive smarter and extra environment friendly high quality administration.

It has strengthened clever administration and threat prevention by digitalization of the provision chain, high quality and manufacturing. Its twin‑platform procurement system integrates provider knowledge and consumer suggestions for actual‑time high quality optimization. Manufacturing digitalization allows full parameter monitoring, facial recognition for key processes, and actual‑time SPC analytics. The digital high quality platform makes high quality seen, controllable, and assessable — decreasing dangers and making certain product reliability.

Haier Biomedical’s sensible IoT manufacturing facility adopts automation, digitalization, and clever connectivity to exactly management manufacturing and dynamically monitor high quality, successfully decreasing in-process high quality dangers. The firm can be constructing clever medical factories that combine gear, knowledge, and controls to set up a full lifecycle manufacturing administration mannequin.

Driven by its imaginative and prescient to be “Making Life Better,” Haier Biomedical is devoted to enhancing affected person nicely‑being globally whereas making high quality merchandise accessible to extra customers. The firm collaborates carefully with worldwide public welfare organizations, supporting communities by money and product donations, totaling 1.406 million yuan (USD 205,697.8) through the reporting interval.

Leveraging its know-how and experience, Haier Biomedical works with governments, NGOs, and universities to advance world well being fairness and make high quality medical providers extra accessible. As a lengthy‑time period associate of GAVI, the corporate helps world immunization by its merchandise. Since its inception in 2000, GAVI has served 1.2 billion youngsters worldwide, considerably bettering little one well being.

Haier Biomedical has made regular progress in its lengthy‑time period environmental investments, increasing its inexperienced product portfolio throughout power saving, eco‑pleasant supplies, full lifecycle planning, and inexperienced packaging. The firm has considerably diminished product power consumption by improvements like Eco‑Drive know-how and zero‑carbon photo voltaic direct‑drive chilly storage.

During the reporting interval, Haier Biomedical obtained 122 power‑saving certificates masking 75 product fashions and added two new ENERGY STAR licensed fashions, bringing the overall to 34. The firm has additionally partnered with establishments reminiscent of Eurofins, the University of Sheffield, and the University of Liverpool, offering low‑carbon gear to help analysis whereas decreasing environmental influence.

Furthermore, Haier Biomedical is dedicated to a various, equitable, and inclusive office and steady expertise improvement, with expanded twin profession tracks for administration and technical professionals. In late March 2026, following board and shareholder approval, the corporate established a compensation incentive fund to help fairness incentives and worker inventory possession plans as a part of its medium‑ to lengthy‑time period incentive applications.

Looking forward, Haier Biomedical will proceed its digital, world, and platform-driven transformation to construct a world-leading built-in life science instruments and clever productiveness platform.

For extra info, please go to: https://www.haiermedical.com/.

View unique content material:https://www.prnewswire.co.uk/news-releases/haier-biomedical-publishes-2025-sustainability-report-committed-to-building-a-platform-for-technology-industry-and-social-responsibility-302777078.html